Peloton Wealth Strategists »

Neurocrine Biosciences shares owned by Peloton Wealth Strategists

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Peloton Wealth Strategists from 13F filings

Historical chart of Peloton Wealth Strategists investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Peloton Wealth Strategists consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Peloton Wealth Strategists

Quarter filed Position value Share count Share price at filing
2024-09-30 $405k 3.5k 115.22

More positions owned by Peloton Wealth Strategists

Mastercard Incorporated Cl A Stock (MA)
Thermo Fisher Scientific Stock (TMO)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Amazon Stock (AMZN)
Ishares Ibonds Dec 2028 Term Corporate Etf Etf (IBDT)
Microsoft Corp Stock (MSFT)
Ishares Ibonds Dec 2025 Term Corporate Etf Etf (IBDQ)
Ishares Ibonds Dec 2027 Term Corporate Etf Etf (IBDS)
Salesforce Stock (CRM)
Ishares Ibonds Dec 2026 Term Corporate Etf Etf (IBDR)
Ishares Ibonds Dec 2029 Term Corporate Etf Etf (IBDU)
Unitedhealth Group Stock (UNH)
Rtx Corporation Stock (RTX)
Applied Matls Stock (AMAT)

View all positions for Peloton Wealth Strategists

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences